Trials / Completed
CompletedNCT00182390
Premature Infants in Need of Transfusion (PINT)
A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 424 (planned)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 48 Hours
- Healthy volunteers
- Not accepted
Summary
Hypothesis: That a high hemoglobin threshold for transfusion in extremely low birth weight (ELBW) infants is associated with a lower rate of survival without severe morbidity (defined as one or more of retinopathy of prematurity, bronchopulmonary dysplasia, or periventricular leukomalacia/ventriculomegaly). Primary Objective: To determine whether either a liberal or more restrictive threshold of hemoglobin level for red cell transfusion in ELBW infants is safer, by randomizing to either a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold. Follow-up at a corrected age of 18 months represents a conventional age at which to first assess neurodevelopmental outcomes, and to predict long-term outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Red blood cell transfusion |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2003-02-01
- Completion
- 2005-11-01
- First posted
- 2005-09-16
- Last updated
- 2015-09-24
Locations
10 sites across 3 countries: United States, Australia, Canada
Source: ClinicalTrials.gov record NCT00182390. Inclusion in this directory is not an endorsement.